192 related articles for article (PubMed ID: 26881929)
1. E2F1 and NF-κB: Key Mediators of Inflammation-associated Cancers and Potential Therapeutic Targets.
Huang Y; Chen R; Zhou J
Curr Cancer Drug Targets; 2016; 16(9):765-772. PubMed ID: 26881929
[TBL] [Abstract][Full Text] [Related]
2. NF-κB and the link between inflammation and cancer.
DiDonato JA; Mercurio F; Karin M
Immunol Rev; 2012 Mar; 246(1):379-400. PubMed ID: 22435567
[TBL] [Abstract][Full Text] [Related]
3. Effect of NF-κB signaling on apoptosis in chronic inflammation-associated carcinogenesis.
Wang H; Cho CH
Curr Cancer Drug Targets; 2010 Sep; 10(6):593-9. PubMed ID: 20482486
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and cancer: when NF-kappaB amalgamates the perilous partnership.
Dobrovolskaia MA; Kozlov SV
Curr Cancer Drug Targets; 2005 Aug; 5(5):325-44. PubMed ID: 16101381
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory mediators of endothelial injury in sickle cell disease.
Hoppe CC
Hematol Oncol Clin North Am; 2014 Apr; 28(2):265-86. PubMed ID: 24589266
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-kappaB upon TLR4 activation.
Lim CA; Yao F; Wong JJ; George J; Xu H; Chiu KP; Sung WK; Lipovich L; Vega VB; Chen J; Shahab A; Zhao XD; Hibberd M; Wei CL; Lim B; Ng HH; Ruan Y; Chin KC
Mol Cell; 2007 Aug; 27(4):622-35. PubMed ID: 17707233
[TBL] [Abstract][Full Text] [Related]
7. Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer Treatment.
Zeligs KP; Neuman MK; Annunziata CM
Clin Cancer Res; 2016 Sep; 22(17):4302-8. PubMed ID: 27422962
[TBL] [Abstract][Full Text] [Related]
8. Classic and Novel Signaling Pathways Involved in Cancer: Targeting the NF-κB and Syk Signaling Pathways.
Tang C; Zhu G
Curr Stem Cell Res Ther; 2019; 14(3):219-225. PubMed ID: 30033874
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.
Kauppinen A; Suuronen T; Ojala J; Kaarniranta K; Salminen A
Cell Signal; 2013 Oct; 25(10):1939-48. PubMed ID: 23770291
[TBL] [Abstract][Full Text] [Related]
10. Nucleophosmin/B23 regulates transcriptional activation of E2F1 via modulating the promoter binding of NF-kappaB, E2F1 and pRB.
Lin CY; Liang YC; Yung BY
Cell Signal; 2006 Nov; 18(11):2041-8. PubMed ID: 16725311
[TBL] [Abstract][Full Text] [Related]
11. E2F1: a magic bullet for atherosclerosis?
Dong C; Goldschmidt-Clermont PJ
Circulation; 2002 Nov; 106(21):2640-1. PubMed ID: 12438285
[No Abstract] [Full Text] [Related]
12. Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies.
Gambhir S; Vyas D; Hollis M; Aekka A; Vyas A
World J Gastroenterol; 2015 Mar; 21(11):3174-83. PubMed ID: 25805923
[TBL] [Abstract][Full Text] [Related]
13. Cellular and molecular pathways linking inflammation and cancer.
Porta C; Larghi P; Rimoldi M; Totaro MG; Allavena P; Mantovani A; Sica A
Immunobiology; 2009; 214(9-10):761-77. PubMed ID: 19616341
[TBL] [Abstract][Full Text] [Related]
14. DXXK exerts anti-inflammatory effects by inhibiting the lipopolysaccharide-induced NF-κB/COX-2 signalling pathway and the expression of inflammatory mediators.
Yu Y; Li X; Qu L; Chen Y; Dai Y; Wang M; Zou W
J Ethnopharmacol; 2016 Feb; 178():199-208. PubMed ID: 26571085
[TBL] [Abstract][Full Text] [Related]
15. Cystic Fibrosis from Laboratory to Bedside: The Role of A20 in NF-κB-Mediated Inflammation.
Bannon A; Zhang SD; Schock BC; Ennis M
Med Princ Pract; 2015; 24(4):301-10. PubMed ID: 25925366
[TBL] [Abstract][Full Text] [Related]
16. Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential.
Wong ET; Tergaonkar V
Clin Sci (Lond); 2009 Mar; 116(6):451-65. PubMed ID: 19200055
[TBL] [Abstract][Full Text] [Related]
17. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
19. NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.
Yu L; Li L; Medeiros LJ; Young KH
Blood Rev; 2017 Mar; 31(2):77-92. PubMed ID: 27773462
[TBL] [Abstract][Full Text] [Related]
20. Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway.
Sun Y; Zhao Y; Wang X; Zhao L; Li W; Ding Y; Kong L; Guo Q; Lu N
Oncotarget; 2016 Jun; 7(23):34300-15. PubMed ID: 27102438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
